‌

US Patent 10946087 Vaccine compositions against dengue virus diseases

Patent 10946087 was granted and assigned to Sanofi Pasteur on March, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Sanofi Pasteur

Current Assignee

Sanofi Pasteur

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10946087

Patent Inventor Names

Yves Girerd-Chambaz0

Melanie Saville0

Nadia Tornieporth0

Nicholas Jackson0

Alain Bouckenooghe0

Fernando Noriega0

Date of Patent

March 16, 2021

Patent Application Number

15507952

Date Filed

September 2, 2015

Patent Primary Examiner

‌

Rachel B Gill

Patent abstract

The present invention relates to vaccine compositions that are useful in a method of protecting a human subject against dengue disease.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10946087 Vaccine compositions against dengue virus diseases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API